PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are attending BIO 2018 (http://convention.bio.org/2018/).

For investors attending the BIO 2018, please contact PharmAbcine Investor Relations and business development to schedule a meeting with management at sungwoo.kim@pharmabcine.com.